Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• LLY scores best on the Growth dimension, with a Growth rank ahead of 95.16% of US stocks.
• LLY's strongest trending metric is Growth; it's been moving up over the last 179 days.
• LLY's current lowest rank is in the Momentum metric (where it is better than 9.4% of US stocks).

LLY Stock Summary

• LLY has a market capitalization of $542,313,346,431 -- more than approximately 99.81% of US stocks.
• Price to trailing twelve month operating cash flow for LLY is currently 88.51, higher than 96.91% of US stocks with positive operating cash flow.
• With a price/sales ratio of 18.37, ELI LILLY & CO has a higher such ratio than 94.13% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to ELI LILLY & CO, a group of peers worth examining would be TSM, JNJ, XOM, V, and AVGO.
• LLY's SEC filings can be seen here. And to visit ELI LILLY & CO's official web site, go to www.lilly.com.

LLY Valuation Summary

• LLY's price/earnings ratio is 83.5; this is 206.42% higher than that of the median Healthcare stock.
• LLY's price/earnings ratio has moved up 57.1 over the prior 243 months.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

The 5 year revenue growth rate now stands at 6.96%.
• The year over year net cashflow from operations growth rate now stands at 3.17%.
• Its 4 year price growth rate is now at 87.77%.

Over the past 52 months, LLY's revenue has gone up $4,263,600,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	28,541.4	7,084.4	6,244.8
2022-09-30	29,239.5	7,661.2	6,033.2
2022-06-30	29,070.7	7,107.7	5,691.6
2022-03-31	29,322.8	8,062.5	6,129.3
2021-12-31	28,318.4	7,260.7	5,581.7
2021-09-30	27,758.5	6,919.4	5,972.4

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
• LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
• BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.